Salient — June 2026

• supported FLOWSATATE is a novel framework for single-cell trajectory inference leveraging time-resolved RNA labeling and Optimal Transport.
• supported FLOWSTATE integrates total and labeled RNA to model cell dynamics as a gradient flow in an inferred potential landscape.
• partial The learned potential enables identification of key genes/TFs driving cell fate and prediction of future cellular states. gap: The manuscript claims these capabilities but provides no data or analysis to demonstrate their accuracy, reliability, or quantitative performance within the excerpt.
• unsupported FLOWSTATE improves inference of cellular dynamics and predicts unseen states compared to state-of-the-art methods. gap: The manuscript claims improvement over state-of-the-art methods and successful prediction but presents no data, metrics, or comparative results to substantiate these claims.
• unsupported FLOWSTATE can generalize to unseen data and recover coherent trajectories. gap: The manuscript claims the ability to generalize and recover coherent trajectories but provides no evidence or results from the stated benchmarking to support this.
• partial FLOWSTATE recovered known effects of demethylating treatment and identified candidate genes (e.g., FLI1) in HCT116 colorectal cells. gap: The manuscript states "known effects" were recovered and "candidate genes" identified, but provides no specific details, data, or validation for these findings within the excerpt.
• unsupported FLOWSTATE suggests the Slit/Robo signaling axis is established earlier in motor neuron commitment during neuronal differentiation. gap: The manuscript makes a specific biological claim about the timing of a signaling axis but provides no data, analysis, or comparison to existing literature to support this assertion.
• supported FLOWSTATE is available as a Python package with code for reproducibility.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported ReconEval provides a comprehensive benchmark for systematically assessing gene expression reconstruction quality from single-cell latent representations.
• partial Optimal latent-space design for gene expression reconstruction depends critically on the interplay between the representation and the downstream model. gap: The text states this as a finding but does not present the specific results or analysis that demonstrate this critical interplay between representation and downstream model.
• supported MLP decoders consistently outperform KNN and Transformer decoders across various score categories for gene expression reconstruction.
• supported The performance of KNN decoders for gene expression reconstruction is largely insensitive to the number of neighbors (k) within the tested range.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported CytoGem-XAI achieves high predictive accuracy (R^2=0.862) and substantially outperforms AMN, FBA, and gradient boosting.
• partial CytoGem-XAI uniquely combines hypergraph representation, FBA-parallel interpretable analysis, and sample-specific metabolic characterization. gap: The claim of uniqueness and being the "first" is an assertion based on a summarized literature review, not a detailed comparative analysis presented in the text.
• partial CytoGem-XAI identifies known essential carbon sources (e.g., alanine, malate) and rate-limiting enzymes (e.g., TCA cycle). gap: The text states that biological validation confirms this but does not present the validation methodology or results to support the claim.
• partial CytoGem-XAI provides interpretable insights through perturbation, intervention, and topological weighting modules. gap: The text describes the design of interpretable modules but does not demonstrate the interpretability or the direct parallelism of its insights with classical FBA workflows.
• partial CytoGem-XAI enables sample-specific metabolic characterization, revealing condition-dependent essentiality unavailable in FBA. gap: The text claims this capability but does not demonstrate how it reveals condition-dependent essentiality or provide examples of sample-specific characterization.
• partial Hypergraph neural networks can learn biologically meaningful representations, recapitulating decades of knowledge. gap: The text asserts that the pathway attribution quantitatively recapitulates knowledge but does not present the quantitative data or analysis supporting this claim.
• unsupported CytoGem-XAI reveals N-acetylmuramate as a previously underappreciated essential nutrient. gap: The text states this as a discovery but provides no evidence or methodology for how CytoGem-XAI revealed it or why it is considered essential and underappreciated.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported PRIME consistently recovers cell populations distinguished by transcriptional kinetics across diverse datasets.
• supported PRIME demonstrates superior robustness compared to conventional integration-and-clustering pipelines.
• supported PRIME provides interpretable kinetic parameters linking observed variability to underlying regulatory mechanisms.
• partial PRIME's PGF space representation enables robust inference of latent kinetic structure. gap: The text describes the theoretical benefits of PGFs for robustness but does not provide direct evidence or comparisons demonstrating that the PGF representation itself (separate from the power K-means backbone) is robust to noise, sparsity…
• partial PRIME's power K-means backbone ensures stable optimization for identifying reproducible kinetic states. gap: While the rationale for power K-means is strong and indirect evidence exists, the manuscript does not directly compare PRIME's performance with and without the power K-means backbone to demonstrate its specific contribution to stable optim…
• partial PRIME offers a mathematically principled and practical route for mechanistic cell-state discovery. gap: The manuscript describes the mathematical principles but does not provide direct evidence of PRIME's 'practicality' in terms of computational efficiency or ease of use, nor does it demonstrate its scalability.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported U1 snRNA helps maintain chromatin accessibility by binding to the UACCACA motif within caRNA in intronic regions.
• supported U1 snRNA interacts with chromatin-associated RNAs (caRNA) via a novel, conserved intronic binding motif "UACCACA."
• supported U1 binding to caRNA intronic sites via the UACCACA motif contributes to PCPA suppression.
• supported A stable U1-U3 snRNA-snoRNA duplex is conserved across multiple cell types.
• supported Small nucleolar RNA (snoRNA) is a major target of snRNAs, in addition to caRNA interactions.
• supported snRNA-KARR-seq provides a framework for interrogating snRNA-directed RNA-RNA networks beyond canonical splice-site pairing.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported Sequential delivery of two vectors targeting CFTR and GGTA1 achieved integration efficiencies of 16.5% (lacZ) and 3.4% (CFTR) in porcine epithelial cells.
• partial The dual-locus-targeting method is a potential strategy to improve CFTR replacement efficacy for universal, permanent CF gene therapy. gap: This claim over-generalizes from in vitro porcine cell data to a "universal and permanent gene therapy treatment for CF lung disease" without in vivo or clinical evidence.
• partial The dual-locus-targeting method produces more undesired edits and an increased number of potential off-target sites, mostly at low frequencies. gap: The conclusion about "more undesired edits" and "increased number" is stated without direct comparative evidence against a single-locus method within this study, and the off-target analysis presented is limited.
• unsupported The results enhance understanding of HDR-mediated integration mechanisms, guiding optimization of future gene editing experiments. gap: The text does not provide specific details or analysis of how the study's results enhance the understanding of HDR-mediated integration mechanisms.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported Inosine can be incorporated into DNA nanostructures (DX motif) with proper assembly.
• supported Inosine incorporation in DX motifs leads to a minimal decrease in thermal stability.
• supported Inosine-containing sticky ends enable hierarchical self-assembly of 3D DNA crystals.
• unsupported Canonical complements do not displace inosine-containing strands post-assembly. gap: No data or methodology for this specific finding from strand displacement assays is presented in the excerpt.
• unsupported Canonical complements dominate product formation when competing with inosine-containing strands during assembly. gap: No data or methodology for this specific finding from competition assays is presented in the excerpt.
• partial Inosine is a useful addition to the library of sequence variations in DNA nanotechnology. gap: This overarching claim is partially supported by successful incorporation and crystal formation, but weakened by the lack of evidence for the strand displacement and competition assay claims.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• partial The Xenium dataset was effectively filtered to remove low-quality cells. gap: No data is presented to demonstrate the effectiveness or justification of the chosen filtering thresholds.
• partial Sample-level batch effects were successfully mitigated during data integration. gap: No data is presented to demonstrate the successful mitigation of batch effects (e.g., pre/post-integration visualizations or metrics).
• partial Reliable cell-type annotations were achieved, even for genes not in the Xenium panel, through a robust imputation strategy. gap: No validation or evidence of the accuracy of the imputed cell-type annotations is provided in the text.
• partial Transcriptional programs associated with inferred cell-cell interaction signals can be accurately assessed using their described methodology. gap: The methodology and validity of inferring the initial 'incoming interaction signals' are not described or supported.
• unsupported Immunofluorescence staining provided valid validation data for the study. gap: No validation data or results from immunofluorescence are presented in the text to support this claim.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported Human epithelioids recapitulate the structural organization, cellular composition, and marker expression profiles of their corresponding tissues of origin across different epithelial subtypes.
• supported Human epithelioids exhibit tissue-specific ultrastructural features and epithelial integrity.
• unsupported The new protocol (ALI conditions, retained epithelial explants) achieves more robust long-term maintenance and improved differentiation of human epithelioids. gap: No comparative data is presented to show that the new protocol improves robustness, long-term maintenance, or differentiation compared to the previous method.
• supported Tracheal epithelioids display pseudostratified architecture with specific basal, ciliated, and secretory cell types and functions comparable to native tissue.
• supported Stratified epithelioids (skin, buccal, esophageal) reproduce characteristic squamous organization and differentiation markers.
• supported Urothelium epithelioids (bladder, urethra) recapitulate transitional stratified urothelium with specific cell layers and markers.
• supported Submandibular gland epithelioids contain ductal and acinar-like cells but lack the typical glandular tubular structure found in vivo.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• partial SMARCA4/STK11/KEAP1 triple mutant LUAD is associated with poor survival and high frequency of multisite metastasis. gap: The authors acknowledge that clinical sample availability for triple mutants is statistically limited, weakening the robustness of this specific clinical association.
• partial SMARCA4/STK11/KEAP1 triple mutant LUAD is a prognostically significant disease subset. gap: This conclusion relies on clinical data which the authors themselves state is statistically limited due to low sample availability.
• supported SMARCA4/STK11/KEAP1 triple knockout models show enhanced migration, invasion, and diversified organotropism.
• supported SMARCA4/STK11/KEAP1 triple mutant LUAD (clinical/models) shows upregulation of TGF-β signaling and EMT gene signatures.
• supported SMARCA4/STK11/KEAP1 triple mutant LUAD (clinical/models) shows corresponding changes in chromatin accessibility.
• unsupported TGF-β signaling is a potential therapeutic target for SMARCA4/STK11/KEAP1 triple mutant LUAD. gap: The results section does not present any evidence from the 'interrogated functional dependency' to support that TGF-β signaling is a functional dependency or a therapeutic target, only that it is upregulated.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported FeatureMSEA is a rank-based framework for MSEA directly from metabolic features with ambiguous annotations.
• supported FeatureMSEA avoids arbitrary feature-level significance cutoffs by using the full phenotype-ranked feature list.
• supported FeatureMSEA preserves multiple candidate annotations per feature, performing MSEA without definitive metabolite identification.
• supported FeatureMSEA identifies leading-edge feature-metabolite relationships, using them to iteratively refine and prioritize annotations.
• supported FeatureMSEA was evaluated using simulated datasets with spike-in metabolite sets.
• supported FeatureMSEA was applied to a Huntington's disease case study, demonstrating disease-relevant metabolite set-level interpretation.
• supported Annotation refinement in FeatureMSEA was assessed using confident MS/MS-supported annotations as partial reference evidence.
• supported FeatureMSEA is an accessible computational tool, implemented with code and a Shiny application, integrating with existing workflows.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported gmMAP integrates metabolite GWAS-derived genetic signatures with single-cell and spatial transcriptomics for metabolic inference.
• unsupported gmMAP reduces the impact of single-cell transcriptomic sparsity and technical noise on metabolite-trait inference. gap: No evidence is presented to demonstrate that gmMAP actually reduces sparsity/noise impact compared to other methods or a baseline.
• partial gmMAP enables systematic inference of diverse metabolite-associated features at cellular resolution, extending beyond canonical intracellular networks. gap: The claim of "systematic inference" and "extending beyond canonical networks" is broad, and the excerpt lacks specific data or examples to fully demonstrate this capability across all mentioned metabolite types or the extent of the extensi…
• supported gmMAP incorporates multi-dimensional biological priors to derive pathway-level metabolic-flow activities across cells, tissues, and developmental trajectories.
• partial gmMAP achieved high-specificity prediction of spatially resolved metabolite distribution patterns and reconstructed whole-organ spatial metabolic features across 17 mouse organs. gap: The claim of "high-specificity prediction" is made without presenting the actual evidence or metrics that define this specificity.
• partial gmMAP's accuracy in metabolite identification and relative metabolic-flow inference was validated using paired transcriptomic and metabolomic reference datasets in renal development. gap: While validation is claimed, the specific results, metrics, or methodology of this validation are not detailed in the excerpt, making it impossible to assess the extent of "accuracy."
• partial gmMAP revealed extensive metabolic rewiring across 29 pan-cancer cell populations and decoded inflammation-associated stromal metabolic remodelling in ulcerative colitis. gap: These are presented as findings, but the excerpt does not provide the underlying data, analysis, or specific results to support the claims of "extensive rewiring" or "decoding remodelling."
• unsupported gmMAP provides a versatile framework for connecting metabolic programmes with tissue physiology, disease pathology, and therapeutic intervention. gap: This is a very broad claim of versatility and impact, for which the excerpt provides no direct, comprehensive evidence or demonstration across all listed applications.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• supported DyMoTree models cell fate decisions as nonlinear mappings between progenitor and terminal cell states under explicit lineage constraints.
• partial DyMoTree enables robust inference of early fate bias, identification of fate-specific progenitor substates, and discovery of lineage-specific driver genes. gap: The claim of "robustness" for inference and identification is stated but not explicitly supported with evidence of resilience to noise or variability in the provided text.
• partial DyMoTree outperformed existing methods in resolving early fate biases across simulations, lineage-tracing experiments, and in vivo systems. gap: The specific methods compared, metrics of outperformance, and the extent of the improvement are not detailed in the excerpt.
• partial DyMoTree accurately recovered early fate biases in progenitor states across various experimental conditions. gap: No specific evidence or quantitative metrics are provided in the excerpt to demonstrate the claimed accuracy.
• partial DyMoTree successfully reconstructed dynamic expression trends of key regulators during the second cell-fate decision in mouse embryogenesis. gap: The claim is qualitative; no specific reconstructed trends or validation metrics are provided in the excerpt.
• partial DyMoTree inferred biologically interpretable transition patterns and recovered molecular mechanisms in LUAD and CAR-T immunotherapy datasets. gap: The claims are qualitative; no specific examples of interpretable patterns or recovered mechanisms are provided in the excerpt.
• partial DyMoTree is a general framework for modeling lineage-resolved cell-state dynamics underlying development and disease progression. gap: While diverse applications are listed, the claim of being a "general framework" might be an over-generalization given the limited number of specific applications detailed in the excerpt.
• partial DyMoTree identified a greater number of fate-biased HSPCs, particularly in monocyte/neutrophil branches, often with corresponding lineage barcodes. gap: The significance of identifying a "greater number" and the validation provided by "corresponding lineage barcodes" are not fully explained or quantified in the excerpt.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• partial The new method is simple, budget-friendly, high-resolution, adds <1hr to prep, and reduces consumable costs >90%. gap: The text asserts significant time and cost reductions and high resolution without presenting any comparative data or quantitative evidence.
• unsupported Our method improves target enrichment by >10x when combined with adaptive sampling by introducing an additional restriction site. gap: The text states a quantitative enrichment improvement (>10x) but provides no data, figures, or statistical analysis to substantiate this claim.
• unsupported The method simplifies analysis workflow and has DNA input demand on par with standard sequencing protocols. gap: The text claims simplification of analysis and comparable DNA input without presenting any evidence or comparative data.
• unsupported A biofilm selection experiment illustrates the method's applicability for phenotype-driven enrichment in complex, multipartite genomes. gap: The text refers to an experiment and its illustrative power but provides no details of the experiment or its results to demonstrate applicability.
• unsupported The method demonstrates advantages of native long reads over PCR-based and short reads in TIS regarding sensitivity, specificity, and statistical analysis. gap: The text asserts advantages of long reads and their method over short reads without presenting any comparative data or analysis to support these claims.
• unsupported The method is extremely easy to apply, resulting in greater accessibility and reduced costs compared to Cas9-based approaches. gap: The text claims ease of application and cost reduction compared to other methods without providing any comparative data or evidence.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.

• partial DFVB structurally reduces model complexity in dynamic simulations. gap: The text describes the mechanism for reducing variables and constraints, but the actual impact on computational efficiency (e.g., speedup) is claimed but not demonstrated with results.
• unsupported DFVB preserves the prediction fidelity of conventional DFBA. gap: The claim of "exact transformation" is stated for FBA, not explicitly DFBA, and no results or comparisons are presented to demonstrate DFVB's accuracy against DFBA.
• partial DFVB enables systematic, simulation-based network reduction by identifying and removing inactive reactions. gap: The algorithmic mechanism for identifying and removing inactive pathways is described, but the extent or effectiveness of this reduction is not demonstrated with results.
• unsupported DFVB enhances kinetic parameter identification, leading to lower prediction uncertainty. gap: This is a direct assertion without any presented evidence, mechanism, or comparison to support how parameter identification is enhanced or uncertainty is lowered.
• unsupported DFVB is scalable to high-dimensional genome-scale metabolic models (GEMs). gap: This is a direct assertion without any presented evidence or demonstration of scalability on high-dimensional GEMs.
• unsupported DFVB substantially reduces computational complexity, enabling robust integration. gap: No evidence is presented for the substantial reduction in complexity or the robust integration into standard bioprocess simulation environments.

Claims and gaps are read from the full text by a language model, shown for transparency; they do not affect ranking or selection.